• 약학회지
• /
• 제53권2호
• /
• pp.60-68
• /
• 2009

In terms of chiral issue, two enantiomers of chiral drugs often differ significantly in their pharmacological, toxicological and pharmacokinetic profile. Chiral switches of racemic drugs have been redeveloped as single enantiomers. Several chiral resolution techniques in chirotechnology are introduced and the most used chiral HPLC chromatographic method among several chiral analysis techniques is described with its several advantages. Several types of chiral HPLC columns derived from their chiral selectors are discussed with their property and applications for enantiomer separation.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.167-168
• /
• 2002

Because of the differences between biological and pharmacological properties of chiral drugs in human body, accurate determinations of their optical purities have been in great need. There are two major approaches in chiral separation: indirect method performed under achiral condition, and direct method under the chiral environment. We have been conducting chiral separation of acidic chiral compounds and also amino acidic chiral compounds employing indirect GC methods and direct CE enantiomeric separation methods. (omitted)

• KSBB Journal
• /
• 제15권5호
• /
• pp.415-422
• /
• 2000

Enzymatic resolution is becoming increasingly important in the production of optically active pharmaceutical drugs and is now challenging the traditional synthetic methods for production of a variety of chiral intermediates and products. This article reviews the recent advances in chirotechnology using enzymes as a catalyst to resolve chiral compounds. The review focuses on the recent trends in chirotechnology and the application of enzymes to the production of industrially valuable pharmaceutical drugs.

• Archives of Pharmacal Research
• /
• 제27권10호
• /
• pp.1009-1015
• /
• 2004

Quantitative Structure-Resolution Relationship (QSRR) using the Comparative Molecular Field Analysis (CoMFA) software was applied to predict the chromatographic behaviors of chiral drugs with an amine moiety on the chiral cellobiohydrolase (CBH) columns. As a result of the Quantitative CoMFA-Resolution Relationship study, using the partial least square method, prediction of the behavior of drugs with amine moiety upon chiral separation became possible from their three dimensional molecular structures. When a mixed mobile phase of 10 mM aqueous phosphate buffer (pH 7.0) - isopropanol (95 : 5) was employed, the best Quantitative CoMFA-Resolution Relationship, derived from the study, provided a cross-validated $q^2$ = 0.933, a normal $r^2$ = 0.995, while the best Quantitative CoMFA-Separation Factor Relationship, also derived from the study, yielded a cross-validated $q^2$ = 0.939, a normal $r^2$ = 0.991. When all of these results are considered, this QSRR-CoMFA analysis appears to be a very useful tool for the preliminary prediction on the chromatographic behaviors of drugs with an amine moiety inside chiral CBH columns.

• Bulletin of the Korean Chemical Society
• /
• 제25권5호
• /
• pp.747-750
• /
• 2004

• Journal of Pharmaceutical Investigation
• /
• 제35권1호
• /
• pp.57-63
• /
• 2005

Numerous drugs are chiral because they possess one or more chiral centers. Enantiomers may differ in their pharmacokinetic, pharmacological and toxicological properties. However, the significance of stereochemistry of drugs in their therapeutic uses has received relatively little attention until recently. The US FDA issued a guideline on stereoisomeric drugs in 1992, and the European agency describes tests for new drug substances which are optically active in an ICH(International Conference of Harmonization) guideline. According to the guidance, enantiomers may differ in their pharmacokinetic, pharmacological and toxicological properties. Therefore, in this paper, we examined the recently published Canadian guidance, stereochemical issues in chiral drug development, which will be references to make a guidance on stereochemical issues in chiral drug development in Korea.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.165-166
• /
• 2002

• Bulletin of the Korean Chemical Society
• /
• 제8권1호
• /
• pp.45-47
• /
• 1987

After conversion to their 3,5-dinitrobenzoyl or 3,5-dinitroanilide derivatives, the enantiomers of a number of drugs may be chromatographically separated on various ${\alpha}$-arylalkylamine-derived chiral stationary phases (CSPs). While each CSP used in this study is useful, CSP 1 is best able to resolve the 3,5-dinitroanilide derivative of Ibuprofen while CSP 9 generally gives rather large ${\alpha}$ values for the resolution of 3,5-dinitrobenzoyl derivatives of the enantiomers of ${\beta}$-adrenergic blocking drugs.

• 청정기술
• /
• 제22권2호
• /
• pp.75-81
• /
• 2016

문명의 발달과 더불어 경제적으로 생활이 윤택하여지고 산업기술이 고도화 되어감에 따라 평균수명이 급격히 연장되었고, 건강식품과 의약품에 대한 의존도와 수요도 급격하게 증가하는 추세이다. 최근에는 건강식품과 의약품의 부작용이 사회적인 이슈로 등장하고 부작용이 없는 의약품의 개발, 환경과 식품산업의 건전성 향상을 위해 신속 간편하며 정확하게 건강과 환경을 계측할 수 있는 기술의 개발 또한 시급한 과제로 부각되고 있다. 의약품의 생산 공정뿐만 아니라 소비자 스스로 자기 건강을 자가 진단하고자 하며, 자기가 먹는 음식의 안전성 여부와 자기가 사는 환경의 안전성 여부를 스스로 확인하고자 하는 욕구 또한 증대되고 있다. 본고에서는 키랄 의약품, 기존의 키랄 의약품 분리기술, 분자자기인식 기법, 그리고 분자자기인식 기법에 의한 키랄 의약품 분리기술 개발동향에 대한 간단한 소개와 분자자기인식 기법에 의한 키랄 의약품 분리ㆍ분석 기술 개발 현황과 그 시장성에 대해 고찰하고자 한다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
• /
• pp.278.3-279
• /
• 2003

A chiral stationary phase (CSP) prepared by bonding (18-crown-6)-2,3,11,12-tetracarboxylic acid (18-C-6-TA) to aminopropyl silica gel by HPLC was used in resolving several racemic drugs containing primary amino moiety. Most compounds used in this study were resolved on the CSP using 80％ methanol in water (V/V) containing 10mM sulfuric acid as a mobile phase. These results on the CSP were compared to those on the similar CSP derived from 18-C-6-TA of the same chiral selector by different connecting method.